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Background: Methicillin-resistant Staphylococcus aureus (MRSA) are important pathogens in neonatal and pediatric
intensive care units, which can cause severe infections in hospitalized children. Detection of the mecA gene and
classification of the staphylococcal cassette chromosome mec (SCCmec) permit the characterization of MRSA strains
isolated from infections caused by these microorganisms. In contrast, pulsed-field gel electrophoresis (PFGE) is used
to type MRSA clones. This method is commonly used to analyze the epidemiology of bacteria causing nosocomial
infections. The objective of this study was to detect and characterize MRSA isolated from clinical specimens of
children hospitalized in the neonatal and pediatric intensive care units of the University Hospital of the Botucatu
Medical School.
Methods: A total of 119 S. aureus strains were isolated from clinical specimens and the mecA gene was detected
by PCR. SCCmec was detected by multiplex PCR and the clonal profile was analyzed by PFGE.
Results: The mecA gene was detected in 17.6% (21/119) of the isolates; 42.9% (9/21) of MRSA were characterized
as SCCmec type III and 57.1% (12/21) as type IV. Analysis of the clonal profile of these strains revealed three
distinct clones, with SCCmec type III being related to the Brazilian endemic clone and type IV to clones JCSC4469
and USA800.
Conclusions: Replacement of clonal groups occurred in the neonatal and pediatric units over the period studied,
a fact highlighting the importance of improving hygiene practices and control measures of nosocomial infections
in these units.
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The genus Staphylococcus is a member of the family
Staphylococcaceae, which comprises 49 species and 26
subspecies [1,2]. Staphylococcus aureus is the most im-
portant species of this genus and the causative agent of a
range of infections, such as furuncles, cellulitis, impetigo,
and wound infections. Some of the most severe infections
caused by S. aureus include bacteremia, pneumonia, os-
teomyelitis, acute endocarditis, myocarditis, meningitis,
and abscesses in muscles, genitourinary tract, central ner-
vous system and various intra-abdominal organs [3,4].* Correspondence: cataneli@ibb.unesp.br
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unless otherwise stated.Studies have shown that 60 to 85% of staphylococci
isolated from clinical samples are resistant to methicillin
[5]. Methicillin-resistant Staphylococcus aureus strains
(MRSA) are important pathogens in neonatal (NICU)
and pediatric intensive care units (PICU), which can
cause severe infections in hospitalized children who are
generally exposed to several risk factors, such as prema-
turity, invasive procedures, mechanical ventilation, and
drains [6].
Oxacillin is the drug of choice for susceptibility testing
and treatment of infections caused by Staphylococcus.
Intrinsic resistance of S. aureus to oxacillin is mediated
by the production of a supplemental penicillin-binding
protein (PBP 2a), which is encoded by the mecA gene [7].
This gene is found on a specific mobile genetic elementLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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(SCCmec), which consists of the mecA gene complex, ccr
gene complex, and region J. The mec complex comprises
the mecA gene and its regulatory genes mecI and mecRI.
The ccr gene complex is responsible for the integration
and excision of SCCmec in the chromosome. In contrast,
region J is not essential for the cassette chromosome, but
can carry genes that encode resistance to non-beta-lactam
antibiotics and heavy metals [8]. Eleven SCCmec types
have been described so far [9]. These types are defined
based on the combination of the type of ccr gene complex
and class of the mec gene complex. Subtypes are defined
based on polymorphisms in region J of the same combin-
ation of mec and ccr complexes [8].
SCCmec types I, II and III are classically found in
nosocomial MRSA strains, whereas the other types are
found in community-associated MRSA [10]. SCCmec
type III encodes the largest number of resistance genes
and strains harboring this type are important pathogens
in hospitals where they cause severe infections [11]. In
contrast, type IV is characterized by a smaller size and
lower metabolic cost, a fact selectively favoring this elem-
ent for transfer between staphylococci [12]. Community-
associated MRSA have been reported to cause severe
infections in NICU and PICU patients who never have
been hospitalized [6]. According to these authors, the
most frequent complications caused by these microorgan-
isms are pneumonia and skin and soft tissue infections
and strains carrying SCCmec type IV are the most
common [6].
The increasing occurrence of MRSA in hospitals
makes the typing of these microorganisms important in
order to determine whether the strains involved in noso-
comial infections or in possible foci of transmission are
related to a specific clone, i.e., whether they have a com-
mon origin [13]. Pulsed-field gel electrophoresis (PFGE)
is commonly used to analyze the epidemiology of bacteria
causing nosocomial infections. This method permits to
clearly discriminate strains and to demonstrate the genetic
relationship between isolates with high reproducibility
[13]. The objective of the present study was to detect and
characterize MRSA isolated from clinical specimens of
children hospitalized in the NICU and PICU of the




A total of 119 S. aureus strains isolated from clinical
specimens of children hospitalized in the NICU and
PICU of HC-FMB between 1991 and 2009 were studied.
Thirty-nine of the 76 neonatal strains were isolated from
blood cultures, 22 from secretions, 12 from catheters,
and three from cannulae. In the pediatric ward, 41 of the43 strains were isolated from blood cultures, one from
pleural fluid, and one from peritoneal fluid. The strains
were isolated as described by Koneman et al. [14] on
blood agar plates (Blood Agar Base, Himedia, Mumbai,
India) and suspected colonies were submitted to Gram
staining. After confirmation of morphology and specific
staining, the isolates were identified using catalase and
coagulase tests.
DNA extraction
Total nucleic acid was extracted from S. aureus isolates cul-
tured on blood agar (Blood Agar Base, Himedia, Mumbai,
India), inoculated individually into brain-heart infusion
broth (Oxoid Ltd., Basingstoke, Hampshire, England), and
incubated for 24 h at 37°C. Extraction was performed using
the Illustra kit (Illustra™, GE Healthcare, Pittsburg, PA,
USA), which consisted of initial digestion of bacterial cells
with lysozyme (Amresco®, Solon, Ohio, USA) (10 mg/mL)
and proteinase K (GE Healthcare, Pittsburg, PA, USA)
(20 mg/mL). Five hundred μL of the extraction solution
(Illustra™, GE Healthcare, Pittsburg, PA, USA) was added
and the mixture was centrifuged (Centrifuge 5804 R,
Eppendorf AG, Hamburg, Germany) at 5,000 × g for 1 min.
The supernatant was transferred to a column and cen-
trifuged (Centrifuge 5804 R, Eppendorf AG, Hamburg,
Germany) at 5,000 × g for 1 min. The collected fluid was
discarded and 500 μL extraction solution (Illustra™, GE
Healthcare, Pittsburg, PA, USA) was added again to the
column. After centrifugation and discarding of the collected
fluid, 500 μL washing solution (Illustra™, GE Healthcare,
Pittsburg, PA, USA) was added and the column was cen-
trifuged (Centrifuge 5804 R, Eppendorf AG, Hamburg,
Germany) at 20,817 × g for 3 min. The column was trans-
ferred to a 1.5-mL tube and 200 μL Milli-Q water heated to
70°C was used for elution. The samples were centrifuged
(Centrifuge 5804 R, Eppendorf AG, Hamburg, Germany) at
5,000 × g for 1 min and the column was discarded. The
extracted DNA was stored in a refrigerator (Brastemp
BRD45, Whirlpool S.A., São Paulo, Brazil) at 4°C.
Detection of the mecA gene
The mecA gene was investigated in the S. aureus isolates
for detection of oxacillin resistance. The primers and
parameters described by Murakami et al. [15] were used
for amplification: primers mecA1 (AAA ATC GAT GGT
AAA GGT TGG) and mecA2 (AGT TCT GCA GTA
CCG GAT TTG) that amplify a fragment of 533 bp.
International reference strains were included as positive
(S. aureus ATCC 33591) and negative (S. aureus ATCC
25923) controls in all reactions.
Determination of the SCCmec type
The SCCmec type was determined in the MRSA iso-
lates by multiplex PCR. The primers and parameters
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amplification.
Pulsed-field gel electrophoresis
The clonal profile of the Staphylococcus spp. isolates was
determined using the modified protocol of McDougal
et al. [17]. The strains were inoculated into brain-heart
infusion broth (Oxoid Ltd., Basingstoke, Hampshire,
England) and incubated for 24 h at 37°C. The isolates
were centrifuged (Centrifuge 5804 R, Eppendorf AG,
Hamburg) in microtubes at 15,294 × g for 1 min, the
supernatant was discarded, 300 μL TE solution
(10 mM Tris, 1 mM EDTA, pH 8.0) was added, and
the strains were kept in a water bath for 10 min at
37°C. The cells were lysed by the addition of 5 μL
lysostaphin (from Staphylococcus lyophilized powder,
Sigma-Aldrich) and vortexed (Phoenix AP-56), and
300 μL of 1.8% low-melt agarose (Agarose-Low Melt,
USB Corporation, Ohio, USA) was added at 37°C.
Plugs were prepared from the strains and the agarose
(Agarose-Low Melt, USB Corporation, Ohio, USA) was
allowed to solidify. The plugs were transferred to a 24-
well plate containing 2 mL EC solution (6 mM Tris-HCl,
1 M NaCl, 100 mM EDTA, 0.5% Brij-58, 0.2% sodium
deoxycholate, 0.5% sodium lauroyl sarcosinate) and incu-
bated for 4 h at 37°C. The EC solution (6 mM Tris-HCl,
1 M NaCl, 100 mM EDTA, 0.5% Brij-58, 0.2% sodium
deoxycholate, 0.5% sodium lauroyl sarcosinate) was
removed and the plugs were washed four times in
2 mL TE solution (10 mM Tris, 1 mM EDTA, pH 8.0) for
30 min at 21°C.
One-third of the plug and 2 μL SmaI (Fast Digest
SmaI, Thermo Scientific, Lithuania, EU) were used for
the restriction of genomic DNA. For restriction, buffer
without the enzyme (45 μL Milli-Q water and 5 μL of
the enzyme buffer) was added to a 96-well plate and the
plate was stored in a refrigerator (Brastemp BRD45,
Whirlpool S.A., São Paulo, Brazil) for 30 min at 4°C. The
buffer without enzyme was removed and buffer con-
taining the enzyme (43 μL Milli-Q water, 5 μL enzyme
buffer, and 2 μL of the enzyme) was added. The plate
was incubated in an oven (Eletrolab 101 M/3, São Paulo,
Brazil) for 6 min at 37°C. Electrophoresis was carried
out in a CHEF-DR III System (BioRad Laboratories,
Hercules, California USA) using 1% agarose gel (Pulsed-
Field Certified Agarose, BioRad Laboratories, USA) pre-
pared in 0.5 M TBE (0.1 M Tris, 0.08 M boric acid,
1 mM EDTA) under the following conditions: pulse
times of 5 to 40 s for 21 h on a linear ramp; 6 V/cm;
angle of 120°; 14°C; 0.5 M TBE as running buffer. The
Lambda Ladder PFG Marker (New England BioLabs,
Hitchin, United Kingdom) was used as a molecular
marker. The gels were stained with GelRed (400 mL
distilled, water and 30 μL GelRed) (10,000X in water,Biotium, Hayward, CA) for 1 h and photographed under
UV transillumination.
The BioNumerics software, version 6.1 (Applied Maths,
Belgium), was used for analysis of similarity, calculation of
the Dice correlation coefficient, and construction of the
dendrogram by the UPGMA method (unweighted pair
group method using arithmetic averages). Band position
tolerance and optimization were set at 1.25 and 0.5%,
respectively. A similarity coefficient of 80% was chosen for
the definition of clusters.
International clones kindly provided by Dr. Antonio
Carlos Campos Pignatari, Laboratório Especial de Micro-
biologia Clínica, Disciplina de Infectologia, Universidade
Federal de São Paulo/Escola Paulista de Medicina, and by
Dr. Agnes Marie Sá Figueiredo, Universidade Federal do
Rio de Janeiro, Instituto de Microbiologia Prof. Paulo de
Góes, Brazil, were used as controls: USA800 (SCCmec
IVa), JCSC 1968/CA05 (SCCmec IVa), JCSC 978/8/6-3P
(SCCmec IVb), MR108 (SCCmec IVc), JCSC 4469 (SCCmec
IVd), WB72/USA300 (SCCmec IV), USA400 (SCCmec IV),
USA500 (SCCmec IV), 0SPC (SCCmec IV), HAR24/
EMRSA 15 (SCCmec IV), HU25 (SCCmec IIIa), 85/2082
(SCCmec III), and ANS 46 (SCCmec III).
Results
The mecA gene was detected in 17.6% (21/119) of the S.
aureus isolates studied. MRSA were detected in 18.4%
(14/76) of the S. aureus strains isolated from the NICU,
including seven strains isolated from blood cultures, four
from secretions, and three from catheters. Seven 16.3%
(7/43) strains from the PICU carried the mecA gene,
including six strains isolated from blood cultures and
one strain isolated from pleural fluid (Table 1).
Characterization of the staphylococcal cassette
chromosome mec
The 21 mecA gene-positive S. aureus isolates were
submitted to multiplex PCR for characterization of the
SCCmec type. Nine of the 21 strains (42.9%) were classi-
fied as type III and 12 (57.1%) as type IV. Eight of the
nine MRSA type III strains were isolated from clinical
specimens of children hospitalized in the NICU and one
in the PICU. Six of the type IV strains were isolated in
the NICU and six in the PICU (Table 1).
Evolution of oxacillin resistance in S. aureus strains isolated
from patients seen at HC-FMB
Analysis of the period from 1991 to 2009 showed the
early presence of SCCmec type IV in a strain isolated
in 1993. Although the sample size of this study was
too small to detect a significant difference, the results
showed a decrease in the prevalence of SCCmec type
III and a recent increase in SCCmec type IV-carrying
isolates.
Table 1 Detection of MRSA and SCCmec type according to hospital ward and clinical specimens
Neonatal intensive care unit Pediatric intensive care unit
N % MRSA SCCmec type N % MRSA SCCmec type
Type III Type IV Type III Type IV
Blood culture (N = 80) 39 17.5 2 5 41 14.6 1 5
Secretion (N = 22) 22 18.2 3 1 0 0 0 0
Fluida (N = 2) 0 0 0 0 2 50.0 0 1
Foreign bodyb (N = 15) 15 20.0 3 0 0 0 0 0
N: number of strains.
aPeritoneal and pleural fluid.
bcatheter and cannula.
Pereira et al. Annals of Clinical Microbiology and Antimicrobials 2014, 13:50 Page 4 of 6
http://www.ann-clinmicrob.com/content/13/1/50Analysis of the clonal profile of MRSA
Analysis of the clonal profile of the MRSA strains
isolated in this study revealed four distinct clones.
MRSA harboring SCCmec type III were divided into two
groups, one related to the Brazilian endemic clone (HU25).
The strains carrying SCCmec type IV were also divided
into two groups, one related to a clone found in the United
States (USA800) and the other related to a clone found in
Japan (JCSC4469) (Figure 1).Figure 1 Determination of the clonal profile of MRSA carrying SCCme
hospitalized in the neonatal (NICU) and pediatric (PICU) intensive carDiscussion
Oxacillin-resistant Staphylococcus aureus are important
pathogens involved in infections that affect children
hospitalized in intensive care units in many countries.
Although the frequency of oxacillin resistance is high
among S. aureus strains, particularly in large hospitals
and universities, the frequency of isolation of MRSA in
the NICU and PICU of HC-FMB was 17.6% (21/119) over
a period of 18 years; 18.4% (14/76) of these isolates werec type III and type IV isolated from clinical specimens of children
e units of HC-FMB.
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lar results have been reported in a study conducted in the
United Kingdom, in which S. aureus strains isolated in the
NICU and PICU of a hospital over a period of 10 years
(1993 to 2003) were analyzed. The frequency of isolation
of MRSA related to bacteremia was 15.1% (5/33) [18]. In a
study conducted in New Zealand, the frequency of isola-
tion of MRSA was 12.0% (7/58) in a PICU over a period
of 11 years (1993 to 2004) [19]. In contrast, different re-
sults were found in the NICU of a hospital in the United
States where 47.4% (8/17) of MRSA were detected among
S. aureus over a period of 10 years (2000 to 2009) [20].
In the two wards, the S. aureus strains isolated from
blood cultures exhibited a similar percentage of oxacillin
resistance [NICU: 17.5% (7/39), PICU: 14.6% (6/41)]. In
the NICU, MRSA were also isolated from other clinical
specimens such as secretions [18.2% (4/22)] and catheters
and cannula [20.0% (3/15)]. In the PICU, only one strain
isolated from pleural fluid was resistant to oxacillin.
Among the MRSA detected in this study, 57.1% (12/21)
were characterized as SCCmec type IV; of these, 83.3%
(10/12) were isolated from blood cultures. In the study of
Healy et al. [21], 75% (6/8) of MRSA strains isolated in
the NICU were typed as SCCmec type IV. SCCmec type
IV is the most frequent type found in the community
and is also becoming predominant among healthcare-
associated MRSA infections [8,22,23]. The smaller size
of the cassette chromosome when compared to types
I, II and III probably increases its mobility and transfer
capacity between Staphylococcus, suggesting that clones
carrying this SCCmec element may spread more easily
and that diseases caused by these strains tend to increase
[24,25]. According to Dolapo et al. [20], the incidence of
MRSA infections in NICUs is still unacceptably high. This
fact may be related to the acquisition of community-
associated MRSA strains, which have evolved in the com-
munity and penetrated the NICU through parents or care
providers.
SCCmec type III was identified in 42.9% (9/21) of
MRSA and predominated among strains isolated in the
1990s. Only one strain was detected after 2000. SCCmec
type III is commonly found in Brazilian hospitals and is
highly resistant to various antimicrobial agents used
to treated S. aureus infections, including resistance to
beta-lactams, macrolides, aminoglycosides and trime-
thoprim–sulfamethoxazole [26]. In the study of Perez &
D’Azevedo [27], nine MRSA were susceptible only to
vancomycin, linezolid and teicoplanin. Eight of these
strains carried SCCmec type III.
In the present study, SCCmec typing permitted to
confirm the isolation of two types of MRSA in the NICU
and PICU of HC-FMB over a period of 18 years. One
important finding was the isolation of MRSA carrying
SCCmec type IV in 1993 from the secretion sample of anewborn. SCCmec type IV was only typed again 10 years
later in the pleural fluid sample of a child hospitalized in
the pediatric unit. From that time on, this SCCmec was
the predominant type among all MRSA isolated in the
two units. According to Milheiriço et al. [16], the SCCmec
element is an important marker for the determination of
MRSA clones. In addition to being a valuable tool for the
study of MRSA epidemiology, SCCmec characterization
permits to investigate the evolution of MRSA clones in
culture collections.
With respect to the epidemiology and evolution of
MRSA clones, PFGE permitted a better analysis of the
data obtained in this study. The MRSA isolates carrying
SCCmec type III were divided into two groups, one of
them related to the Brazilian endemic clone (HU25).
According to Vivone et al. [28], this clone is responsible
for most infections caused by MRSA. The MRSA isolates
carrying SCCmec type IV could also be divided into two
groups, one related to clone JCSC4469 and the other
related to clone USA800. The strain mentioned above,
which was isolated in 1993 and carried SCCmec type
IV, was related to clone USA800. This group comprised
strains isolated between 1993 and 2005. Trindade et al.
[29] found a variety of MRSA that were related to the
Brazilian endemic clone. In the present study, strains
related to the Brazilian endemic clone predominated
until 2003, whereas strains related to clones JCSC4469
and USA800 were found after this period. A Brazilian
study conducted in a university hospital that analyzed
clonal groups over a period of 8 years found that the
clones identified were replaced over time, without any
predominance in a specific hospital area [30]. According
to the authors, replacement of clonal groups over time
might be explained by microevolution of the pathogen or
by competition to adapt to the hospital environment.
Furthermore, the report of the presence of the pediatric
clone in central Brazil suggests that this clone is settling in
Brazilian hospitals and spreading in the community, in-
creasing the likelihood of expanding its reservoir [31].
Conclusions
The clonal MRSA groups found in the NICU and PICU
of HC-FMB highlight the importance of improving
hygiene practices and control measures of nosocomial
infections in these units since hospitalized children
are generally more vulnerable because of exposure to
several risk factors. Furthermore, the clonal groups that
predominated over the past years carry SCCmec type IV,
an element that does not impose any metabolic cost on the
host and that may spread in the absence of antibiotic
selective pressure. This fact may result in the emergence
of this type as a new pathogen in the world. Although the
sample size of this study was too small to draw any defin-
ite conclusions, according to the literature, community-
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place or be the more dominant population in clinical
settings.
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